Security record · archived quarter
USNA
USANA Health Sciences, Inc. · Consumer Defensive · Household & Personal Products
2Tracked holders
0Δ holders
38.43KShares held
$556,110Reported value
+0New positions
−0Exits
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2026
Ownership over time
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q3 2026 | 2 | 0 | 38.43K | $556,110 | n/a | n/a |
| Q2 2026 | 61 | -2 | 7.74M | $165.20M | +4 | −6 |
| Q1 2026 | 65 | +3 | 6.89M | $120.47M | +5 | −2 |
| Q4 2025 | 62 | -2 | 7.80M | $153.11M | n/a | −2 |
| Q3 2025 | 17 | +1 | 5.59M | $154.00M | +1 | n/a |
| Q2 2025 | 13 | +1 | 5.14M | $156.91M | +2 | −1 |
| Q1 2025 | 9 | -1 | 2.31M | $62.36M | n/a | −1 |
| Q4 2024 | 10 | +2 | 2.26M | $81.25M | +2 | n/a |
| Q3 2024 | 7 | -2 | 1.82M | $68.95M | n/a | −2 |
| Q2 2024 | 9 | n/a | 1.79M | $80.79M | n/a | n/a |
Who holds it · Q3 2026
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Assenagon Asset Management S.A. | 38.21K | -50.0% | $552,942 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 2 | TD Waterhouse Canada Inc. | 220 | 0.0% | $3,168 | 0.0% | Held | 3 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 137 holders, 10.29M shares, $176.85M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
Frequently co-owned
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.
Provenance: Ownership from parsed 13F common-stock positions (tracked universe, comparable sets for changes); insider rows from Forms 3/4/5; stakes from Schedules 13D/13G; every filing links to its original on SEC EDGAR.
Reporting period: Q3 2026 ·
Methodology ·
Get this via the API